The Tube That Outlived Empires
Somewhere in the world, right now — in a concrete-block shop in rural Maharashtra, in a fluorescent-lit Walmart in Bentonville, on a pharmacy shelf in São Paulo, in a kiosk at a Lagos bus depot — someone is reaching for a tube of Colgate. Not a toothpaste. Colgate. In dozens of languages and across more than 200 countries and territories, the brand name has become so thoroughly synonymous with the product category that it has undergone the rarest of commercial transubstantiations: it has ceased to be a brand and become a generic noun. Ask for toothpaste in parts of India, Latin America, or sub-Saharan Africa, and the word that comes back is Colgate. The company claims approximately 40% of the global toothpaste market. Its brand appears in more households worldwide than any other single product — not Coca-Cola, not Tide, not the iPhone. In 2015, Colgate-Palmolive disclosed that its namesake oral care brand was the only one on earth purchased by more than half of all global households, with a penetration rate approaching 50% and some 40 million new households entering the franchise each year.
That statistic is, on reflection, almost hallucinatory. It describes a consumer goods company founded two years before the Embargo Act of 1807, before the War of 1812, before the Monroe Doctrine — a firm that began life making tallow candles and bars of soap in a rented loft on Dutch Street in lower Manhattan, and which today, more than two centuries later, generates nearly $20 billion in annual revenue by selling a product its founder never manufactured. William Colgate died in 1857. His company did not begin selling toothpaste until 1873. The collapsible tube arrived in 1896. The transformation from soap company to oral care empire was not the founder's vision but a multigenerational improvisation — a sequence of pivots, mergers, and strategic bets that turned a regional soap-and-candle operation into the closest thing the consumer products industry has to a permanent institution.
The paradox at the heart of Colgate-Palmolive is this: it is one of the most geographically ubiquitous companies ever built, operating in every corner of the planet, yet it competes in categories — toothpaste, dish soap, bar soap, pet food — so mundane that most investors and analysts rarely give it sustained attention. It is not a platform. It has no network effects. It does not benefit from the zero-marginal-cost economics that enchant Silicon Valley. What it has instead is something rarer and arguably more durable: the compound interest of trust, accumulated over 219 years, embedded in the daily habits of billions of people who do not think about Colgate because they do not need to. They just buy it. Again and again and again.
By the Numbers
The Colgate-Palmolive Empire
~$20BNet sales (FY2024)
~40%Global toothpaste market share
200+Countries and territories served
~34,000Employees worldwide
~$62BApproximate market capitalization
219Years in continuous operation
~31%Global manual toothbrush market share
1806Year founded
The Immigrant's Wager
The story begins not with teeth but with tallow. Robert Colgate was an English farmer from Sevenoaks in Kent, a Whig sympathizer who had the misfortune of being too vocal about his support for the American and French revolutions during a period when such sympathies could ruin a man. In March 1795, he packed his family aboard the ship Eliza and sailed for Baltimore, arriving after seventy days at sea. Among his eleven children was William, born on January 25, 1783, in Hollingbourne, England — a boy who would grow up on the American frontier knowing that his family had been exiled for their politics. It was the kind of origin story that breeds a particular species of ambition: not the swaggering confidence of inherited wealth, but the grim, methodical determination of a person who understood that survival in the New World required usefulness.
William Colgate arrived in New York City in 1804, twenty-one years old, with, by his own later account, scarcely a cent. He entered the counting-room of John Slidell & Co., then the largest tallow chandlers in the city, at 50 Broadway. The salary was small. But — and this detail, relayed in his 1857 obituary in the New York Tribune, captures the man — "it was not the salary, it was the business that he wished." Within three years he was the firm's principal business manager. When the partnership dissolved, he had learned the trade from the inside.
In 1806, at twenty-three, William Colgate opened his own soap and candle manufactory at 6 Dutch Street. The location was not accidental. The Mayor of New York lived on Dutch Street. Prominent citizens passed the little factory daily, and their out-of-town visitors would carry back impressions of the enterprise — a form of brand awareness that predated the concept by a century. The business was initially listed as "Smith and Colgate, tallow chandlers" in the 1807 Longworth's New York Register. By 1820, after the partnership dissolved, it became William Colgate & Company.
For the next four decades, Colgate built a regional soap and candle business of increasing scale and respectability. He was a devout Baptist, a generous philanthropist — he would become a major benefactor of the institution that would eventually bear his family's name, Colgate University — and a meticulous businessman who understood that the market for essential household goods was, in principle, as large as the population itself. He added toilet soaps to the product line in 1847, a decade before his death. The shift was prophetic. Tallow candles would be made obsolete by kerosene and then electricity. Toilet soap, by contrast, was tied to something more permanent than any technology: the human body's daily demand for hygiene.
🕯️
From Candles to Cavities
Key milestones in Colgate's first century
1806William Colgate opens soap and candle shop at 6 Dutch Street, New York City.
1847Company adds toilet soaps to its product line.
1857William Colgate dies; son Samuel and nephew Charles take over as Colgate & Company.
1873Colgate begins selling toothpaste — in jars.
1896Colgate introduces toothpaste in a collapsible tube, a format innovation that defines the category.
1906Company celebrates its centennial with a national reputation in personal care.
1928Merger with Palmolive-Peet creates Colgate-Palmolive-Peet Company.
The Accidental Oral Care Company
William Colgate never sold a tube of toothpaste. That fact deserves emphasis because it illuminates something essential about the company's DNA: Colgate-Palmolive is not a company built on a single founder's product vision. It is a company built on institutional adaptability — the capacity to identify where human hygiene habits are heading and to position itself there before the market fully materializes.
When Colgate & Company began selling toothpaste in jars in 1873, sixteen years after the founder's death, it was entering a nascent market. Toothpaste as a mass consumer product barely existed. The Egyptians had used abrasive pastes as early as 5000 BC, and the Chinese had experimented with herbal mints and salt for centuries, but the modern toothpaste industry was an invention of the nineteenth century. Early formulations contained soap; by the 1850s, chalk was a standard ingredient. The product was sold as a powder or a paste in a jar — messy, inconvenient, and difficult to dose.
Colgate's decisive format innovation came in 1896: toothpaste in a collapsible tube. The idea was not entirely original — collapsible metal tubes had been used for artist paints since the 1840s — but Colgate was among the first to apply the concept to oral care at commercial scale. The tube was more hygienic than the jar, easier to use, easier to transport, easier to display on a shelf. It was a packaging innovation, not a chemical one, but it transformed the economics of the category. A tube was a single-serving container that encouraged daily use and regular repurchase. It turned toothpaste from an occasional luxury into a habit — and habits, once formed, are the most reliable revenue streams in consumer goods.
In 1930, Colgate became the first brand to receive the American Dental Association's Seal of Approval on its Ribbon Dental Cream. The ADA seal was not merely a marketing badge; it was a credentialing mechanism that established Colgate in the minds of dentists as the scientifically validated choice. This relationship between Colgate and the dental profession — the company today claims the largest partnership with dental professionals of any oral care brand — would become one of the most durable competitive advantages in consumer products. Dentists recommend Colgate. Patients trust their dentists. The recommendation loop compounds over decades. It is not a network effect in the technical sense, but it functions like one: each new dentist who endorses the brand makes it marginally more likely that the next patient will reach for the red tube.
The Merger That Made the Machine
The Colgate family ran the company for three generations. But the transformation from a family soap business into a global consumer products conglomerate required a structural break — and that break came in 1928, when Colgate & Company merged with Palmolive-Peet Company to form Colgate-Palmolive-Peet Company (later shortened to Colgate-Palmolive in 1953).
Palmolive brought something Colgate lacked: a mass-market brand identity in personal care beyond oral hygiene, and a sophisticated advertising operation honed during the golden age of print and early radio. Palmolive soap — made from palm and olive oils, hence the name — had been one of the best-selling soaps in the world by the 1920s. The merger gave the combined entity a portfolio spanning oral care, personal care, and household cleaning, with the distribution infrastructure to push those products through grocery stores, pharmacies, and general merchandise retailers across the United States and, increasingly, overseas.
The timing was brutal. The merged company arrived in the world one year before the Great Depression. But essential hygiene products have a structural advantage during downturns that luxury goods do not: people still brush their teeth. People still wash their hands. The categories Colgate-Palmolive occupied were, almost by definition, recession-resistant. This resilience during the 1930s cemented a pattern that would repeat across every subsequent economic crisis — the company's revenue might slow, margins might compress, but the top line rarely collapses, because its products sit at the base of Maslow's hierarchy. You can defer buying a new car. You cannot defer brushing your teeth.
The small soap and candle business that William Colgate began in New York City early in the 19th century is now, more than 200 years later, a truly global company serving hundreds of millions of consumers worldwide.
The Geography of Toothpaste
Most American consumer products companies expanded internationally in the post-World War II era, riding the wave of American cultural hegemony and Marshall Plan-era trade liberalization. Colgate-Palmolive had been doing it since the 1920s. The company established operations in Europe, Latin America, and parts of Asia before many of its competitors had considered leaving the domestic market. By the time Procter & Gamble launched Crest toothpaste in 1955 — backed by a massive advertising campaign and the ADA's endorsement — Colgate was already a global brand with an entrenched distribution network on multiple continents.
This geographic head start proved to be the company's most important strategic asset. In developed markets like the United States and Western Europe, Colgate and Crest (P&G's oral care brand) have fought a duopoly battle for decades, trading the number-one position back and forth. In 2007, Ad Age reported that Crest wrested the top U.S. market share position from Colgate, aided by its Crest Pro-Health line. But in the rest of the world — in the markets that would define consumer goods growth for the next half-century — Colgate faced less formidable competition and had deeper roots. In India, the brand's name is virtually interchangeable with the product category. In Brazil, Mexico, and across Southeast Asia, Colgate commands market shares that would be considered monopolistic in any other industry.
The strategy was deceptively simple: go where people are starting to brush their teeth for the first time. In emerging markets, oral hygiene adoption correlates with rising incomes, urbanization, and access to running water. As hundreds of millions of people in Asia, Africa, and Latin America crossed the income threshold where daily toothbrushing became habitual, Colgate was already there — on the shelf, at the right price point, with a name that local consumers already associated with oral care. The company did not need to create demand. Modernization created demand. Colgate simply needed to be the brand people reached for when the habit formed.
This explains the company's otherwise puzzling geographic revenue split. While many American consumer products companies derive the majority of their revenue from North America, Colgate-Palmolive generates a significant majority from international markets. The company operates through segments including Oral, Personal and Home Care across North America, Latin America, Europe, and Asia Pacific, plus its Hill's Pet Nutrition division. Latin America alone has historically been one of the company's largest and most profitable regions. For a company headquartered at 300 Park Avenue in Manhattan, Colgate-Palmolive is in many ways more a developing-world company than a developed-world one.
Fluoride Wars and the Crest Challenge
The most consequential competitive battle in Colgate's modern history began on a single evening in 1960, when Procter & Gamble secured the ADA's endorsement for Crest — the first toothpaste to receive the seal for cavity prevention based on its stannous fluoride formula. The endorsement was a thunderbolt. P&G had spent years and millions of dollars on clinical trials, and the ADA's imprimatur gave Crest a claim that Colgate could not match: this toothpaste, and only this toothpaste, is clinically proven to prevent cavities.
Crest's market share surged. By the mid-1960s, it had become the best-selling toothpaste in the United States, a position it would hold for decades. Colgate scrambled. In 1968, the company reformulated its toothpaste with MFP fluoride (sodium monofluorophosphate) to compete on the cavity-prevention claim. It launched Ultrabrite, targeting the emerging whitening segment. But the damage in the U.S. market was done: Crest had claimed the high ground of clinical credibility, and Colgate would spend the next three decades trying to reclaim it.
The response, when it finally came, was Colgate Total. Introduced in 1992, Total was the product of years of R&D investment and a fundamentally different clinical proposition. Rather than competing solely on cavity prevention — Crest's stronghold — Total was formulated with triclosan and a copolymer delivery system that provided twelve-hour protection against gingivitis, plaque, cavities, and tartar buildup simultaneously. It was the first toothpaste to claim efficacy against gingivitis and received FDA approval as an over-the-counter drug — a regulatory distinction that required years of clinical trials and documentation far beyond what a standard cosmetic toothpaste needed.
Colgate Total did not merely restore Colgate's competitive position in the U.S. It redefined the category by elevating the product from a cosmetic to a therapeutic. The strategy was brilliant in its structural logic: by positioning Total as a quasi-pharmaceutical product backed by FDA approval, Colgate created a form of regulatory moat. Competitors could not simply copy the formulation and claim the same benefits; they would need to invest in their own multi-year clinical programs and navigate the same FDA approval process. It was the oral care equivalent of a pharmaceutical patent — not a chemical patent, but a regulatory barrier that functioned similarly.
Hill's: The Pet Food Bet Nobody Saw Coming
In 1976, Colgate-Palmolive made what appeared at the time to be a bewildering acquisition: it purchased Hill's Pet Nutrition, a specialty pet food company founded in 1907 by a veterinarian named Mark L. Morris Sr. Hill's manufactured Science Diet and Prescription Diet — premium, science-based pet food products sold primarily through veterinary clinics and specialty pet retailers rather than grocery stores.
The acquisition made no obvious strategic sense through the lens of traditional consumer products logic. Pet food was not oral care. It was not personal care. It was not household cleaning. Hill's operated through a completely different distribution channel — veterinary clinics — and served a customer base (pet owners willing to pay premium prices on veterinary recommendation) that had no overlap with the value-conscious mass-market shoppers who bought Palmolive dish soap.
And yet. Hill's Pet Nutrition has become one of the most profitable divisions in Colgate-Palmolive's portfolio, consistently generating operating margins that rival or exceed the company's core oral care business. The strategic logic, invisible in 1976, became clear over subsequent decades: Hill's operates in a premium pet food market with powerful secular tailwinds (pet humanization, rising veterinary spending, premiumization of pet care) and a distribution model — recommendation by veterinarians, much as Colgate toothpaste is recommended by dentists — that creates a trust-based moat structurally identical to the one Colgate had built in oral care.
The parallel is almost uncanny. In oral care, Colgate built its competitive advantage by aligning with dental professionals, earning clinical endorsements, and benefiting from the professional-to-consumer recommendation loop. In pet nutrition, Hill's built its competitive advantage by aligning with veterinarians, earning clinical endorsements, and benefiting from the professional-to-pet-owner recommendation loop. Two different categories. Same playbook. Same structural moat. The 1976 acquisition was not a diversification — it was a franchise extension.
Colgate-Palmolive is the parent company of Hill's Pet Nutrition, which sells its products through pet supply retailers and veterinary clinics.
The Restructuring Machine
To look at Colgate-Palmolive from the outside is to see a remarkably stable enterprise — same categories, same brands, same geographic footprint, decade after decade. But beneath that placid surface, the company has been in near-constant operational restructuring for the better part of thirty years. The pattern is characteristic of mature consumer staples companies competing in low-growth categories: because top-line growth is structurally limited (toothpaste markets grow at roughly the rate of population growth plus a small premiumization tailwind), margin expansion becomes the primary lever for earnings growth.
Colgate-Palmolive has executed this playbook with relentless consistency. The company has undertaken multiple restructuring programs since the early 2000s, each targeting manufacturing consolidation, supply chain optimization, overhead reduction, and SKU rationalization. The restructuring charges show up in the financial statements as one-time items, but they recur so regularly that they are effectively a permanent feature of the company's operating model — a continuous improvement engine disguised as periodic reorganization.
The results are visible in the margin trajectory. Colgate-Palmolive's gross margins have steadily expanded over the past two decades, reaching levels that place it among the most profitable consumer staples companies in the world. The company's operating discipline is the kind of thing that does not generate headlines but compounds over decades: a fraction of a percentage point of gross margin improvement each year, aggregated across a $20 billion revenue base, generates hundreds of millions of dollars in incremental operating income.
This is the deeply unglamorous work of consumer staples management — the factory closures, the procurement negotiations, the advertising efficiency studies, the distribution route optimizations — and it requires a particular species of executive: not the visionary founder type, not the charismatic dealmaker, but the process engineer. The kind of person who gets excited about extracting fifteen basis points from the cost of goods sold.
Noel Wallace and the Innovation Imperative
Noel Wallace became CEO of Colgate-Palmolive in 2019, succeeding Ian Cook, who had led the company for over a decade. Wallace — a Colgate lifer who had spent his career rising through the company's international operations — inherited a business with an extraordinary market position and a nagging strategic vulnerability: the oral care category, Colgate's fortress, was showing signs of disruption.
Direct-to-consumer brands had begun entering the oral care space. Procter & Gamble was investing aggressively in electric toothbrushes through its Oral-B brand. Whitening products were proliferating. Natural and organic toothpaste brands like Tom's of Maine (which Colgate had acquired in 2006) and newcomers were attracting younger consumers who wanted cleaner ingredient lists. The premium end of the toothpaste market was growing faster than the mass end, and Colgate — despite its global dominance — was disproportionately positioned in the mass tier.
Wallace's response has been a multi-pronged premiumization strategy. Colgate Optic White, launched in 2011 with the first toothpaste formula to contain a professionally recommended whitening agent, has been expanded into a full sub-brand targeting the high-margin whitening segment. The company has invested in innovation across its portfolio — new formulations, premium positioning, digital marketing, and sustainability initiatives. In 2024, Colgate-Palmolive unveiled a refreshed corporate logo integrating a smile into the legacy "CP" mark, accompanied by the tagline "Make More Smiles" — a visual identity update designed, as chief communications officer Dana Bolden put it, to "honor our past, reflect our present, and inspire our future."
Best-in-class companies communicate with clarity, consistency, and confidence — not just in what they say but in how they show up. Our refreshed corporate brand honors our past, reflects our present, and inspires our future.
The real innovation story, though, may be less about new products than about the company's relationship with the dental profession. Colgate claims more patented innovations in oral care than any other company in the category, and the largest partnership with dental professionals globally. The company's Bright Smiles, Bright Futures program — a community oral health education initiative that has operated for decades — reaches hundreds of millions of children worldwide. These programs are not charity. They are infrastructure. Every school visit, every free sample distributed through a dental clinic, every oral health education pamphlet is a touchpoint that reinforces the Colgate brand at the moment of habit formation. The company is not just selling toothpaste; it is teaching the world to brush — and teaching it to brush with Colgate.
The Darkie Problem and the Weight of Global Scale
No profile of Colgate-Palmolive can be complete without confronting the Darkie episode, which illustrates both the complexity and the moral hazard of operating at global scale.
In 1985, Colgate-Palmolive acquired a 50% stake in Hawley & Hazel, a Hong Kong-based company whose best-selling product across Southeast Asia was a toothpaste brand called "Darkie." The tube bore the caricature of a grinning Black man in minstrel garb. The brand was one of the most popular toothpastes in the region, with dominant market share in several Asian markets.
The acquisition triggered years of controversy. As the Washington Post reported in 1990, the brand was "racially offensive, even to the huge American company that for four years has owned 50 percent of Darkie." Colgate's leadership insisted the company was doing everything possible to change the name and logo, but the process was slow — the brand was enormously valuable commercially, and local partners and consumers resisted rebranding. Eventually, the name was changed to "Darlie" and the logo was modified, but the episode exposed a tension that persists in global consumer products: the same geographic ubiquity that makes Colgate powerful also exposes it to local practices, brand histories, and cultural contexts that can be deeply incompatible with the values the parent company espouses.
The Darkie controversy was not an isolated incident but a symptom of a structural challenge. When you operate in more than 200 countries and territories, you inherit the full complexity of those markets — their regulations, their cultural norms, their political risks, their distribution quirks. The company that benefits from selling toothpaste in every corner of the world also bears the risk of every corner of the world.
The Compounding of the Mundane
What makes Colgate-Palmolive difficult to analyze — and easy to underestimate — is that its competitive advantage is essentially invisible. It has no proprietary technology platform. No patent portfolio that expires and triggers a cliff. No charismatic founder whose tweets move the stock. No moonshot project that captures the imagination of CNBC hosts. It has, instead, something that is simultaneously less exciting and more durable: the accumulated compound interest of being the default choice in a category that every human on earth participates in twice a day.
The company's global toothpaste market share — approximately 40%, with approximately 31% of the manual toothbrush market — has been remarkably stable over decades, fluctuating within a band that suggests not stasis but equilibrium. In Q4 2020, the company reported net sales of $4.3 billion, an increase of 7.5% year over year, with organic sales growth of 8.5%. The company continued its leadership position with 39.8% of the global toothpaste market and 31.1% of the global manual toothbrush market. These are not monopoly numbers. But they are monopoly-like numbers in a category where the number-two player (P&G's Crest/Oral-B) holds a meaningfully smaller share globally, and the long tail of local and regional brands fragments the remaining market.
The durability of this position defies the standard narratives about disruption and competitive dynamics. In theory, toothpaste should be eminently disruptable: it is a low-technology product with no switching costs, sold in a highly competitive retail environment. In practice, the category has proven nearly impervious to disruption because the switching costs, while invisible, are enormous — they are embedded not in contracts or data lock-in but in habit, trust, and the extraordinary stickiness of a brand that a consumer's mother used, and her mother before her.
Revenue for fiscal year 2024 reached approximately $20 billion. The company's total brand value is estimated at roughly $62 billion. Colgate-Palmolive's stock has compounded steadily for decades, not at the rates that excite growth investors, but at the rates that build retirement portfolios — the kind of returns that are boring to discuss at dinner parties and deeply impressive on a thirty-year basis.
Two Hundred and Nineteen Years
Consider the span. In 1806, when William Colgate set up his tallow vats on Dutch Street,
Thomas Jefferson was president. Napoleon was conquering Europe. New York City's population was approximately 80,000. The Erie Canal had not been dug. The telegraph had not been invented. The germ theory of disease was six decades away. The very idea of
toothpaste as a daily consumer product did not exist.
Two hundred and nineteen years later, the company William Colgate founded employs approximately 34,000 people, operates in every inhabited continent, and puts its products in the hands of billions of human beings every day. It has survived the Civil War, two World Wars, the Great Depression, the rise and fall of colonial empires, the digital revolution, and a global pandemic. It has outlived every competitor that existed when it was founded. It will, in all probability, outlive most of the companies that exist today.
The secret, if there is one, is not innovation or genius or even strategy in the conventional sense. It is the recognition — intuitive in William Colgate's decision to make soap, formalized over subsequent generations into a corporate operating philosophy — that the most durable businesses are the ones that attach themselves to the most durable human behaviors. People will always need to clean themselves. The technology of cleaning changes. The formats change. The chemistry changes. The brand that earns trust in one generation and maintains it in the next — that brand endures.
On a shelf in the Robert M. Linsley Geology Museum at Colgate University — the institution endowed by William Colgate's descendants, its name forever twinned with the toothpaste company despite having no corporate affiliation — there sits an oviraptor dinosaur egg, one of the first complete dinosaur eggs ever discovered. It has been there for decades. It will be there for decades more. Some things just last.
Colgate-Palmolive has persisted for 219 years not through any single brilliant decision but through the disciplined repetition of a small number of operating principles — principles so deeply embedded in the company's institutional culture that they function less as strategy and more as instinct. What follows are the patterns that have made this particular machine run.
Table of Contents
- 1.Attach to the most permanent human behaviors.
- 2.Own the professional recommendation loop.
- 3.Win the format war, not the formula war.
- 4.Be there when the habit forms.
- 5.Let the portfolio rhyme, not repeat.
- 6.Restructure continuously, not episodically.
- 7.Trade growth rate for growth permanence.
- 8.Make the brand a generic noun.
- 9.Premiumize from a position of mass dominance.
- 10.Survive the century. Then survive the next one.
Principle 1
Attach to the most permanent human behaviors.
William Colgate did not invent soap. His descendants did not invent toothpaste. The company's enduring competitive advantage does not derive from product invention but from category selection: Colgate-Palmolive has, across every generation of its existence, positioned itself in product categories tied to behaviors that are biologically or socially compulsory. People clean their bodies. People clean their teeth. People clean their homes. People feed their pets. These behaviors do not cycle in and out of fashion. They do not depend on economic conditions or technological paradigms. They are, for all practical purposes, permanent features of human civilization.
The strategic implication is profound: when your product category is permanent, your primary risk shifts from demand destruction to competitive displacement. Colgate does not need to worry that people will stop brushing their teeth. It needs to worry only that people will brush their teeth with someone else's toothpaste — a narrower and more manageable risk.
Benefit: Revenue durability that approaches the theoretical maximum for a consumer business. Recessions compress margins but do not destroy demand. Secular trends (population growth, urbanization, hygiene education) are permanent tailwinds.
Tradeoff: Categories tied to permanent behaviors are also, by definition, low-growth categories. You will never see 30% organic revenue growth from toothpaste. The ceiling is real.
Tactic for operators: Before building, ask whether the behavior your product serves is permanent or contingent. If it is contingent on a technology cycle, a cultural trend, or a regulatory environment, you are building on sand. The most durable businesses attach to behaviors that predate and will outlast any particular era.
Principle 2
Own the professional recommendation loop.
Colgate's relationship with the dental profession is not a marketing program. It is the company's core competitive infrastructure. Since receiving the ADA's first Seal of Approval in 1930, Colgate has invested continuously in building and maintaining relationships with dental professionals — through clinical research partnerships, professional education programs, product sampling in dental offices, and the Bright Smiles, Bright Futures community outreach initiative.
The mechanism works as follows: dentists recommend Colgate to patients. Patients trust their dentists — far more than they trust advertisements. The recommendation converts to a purchase. The purchase reinforces the habit. The habit persists for years or decades. When that patient's child visits the dentist, the same recommendation is made. The loop compounds across generations.
Hill's Pet Nutrition operates the identical playbook through veterinary clinics. The professional-to-consumer recommendation channel is the same. The trust dynamics are the same. Colgate-Palmolive essentially discovered a structural competitive advantage and then replicated it in a second category.
How professional endorsement compounds into market share
| Division | Professional Channel | Trust Mechanism | Competitive Result |
|---|
| Oral Care | Dentists & hygienists | ADA Seal, clinical trials, sampling | ~40% global toothpaste share |
| Hill's Pet Nutrition | Veterinarians | Prescription Diet, clinical evidence | Premium pet food leadership |
Benefit: Professional recommendation creates a trust moat that is extremely difficult for competitors to replicate. A new entrant cannot buy this relationship — it must be earned over decades of clinical evidence and institutional engagement.
Tradeoff: Dependence on professional channels creates vulnerability to shifts in professional opinion or regulatory standards. If dental associations change their endorsement criteria, or if veterinarians shift toward alternative nutrition philosophies, the moat can erode.
Tactic for operators: Identify the trusted intermediary in your category — the person whose recommendation your customer values more than any advertisement — and build your entire go-to-market around earning that intermediary's endorsement. This is not a marketing channel. It is a moat-building strategy.
Principle 3
Win the format war, not the formula war.
Colgate's most transformative innovation was not a chemical breakthrough. It was putting toothpaste in a collapsible tube in 1896. The tube did not make the toothpaste better. It made the toothpaste easier to use — more hygienic, more portable, more dosable — and in doing so, it transformed toothpaste from an occasional product into a daily habit.
This pattern recurs throughout Colgate's history. The company's competitive victories have more often been format innovations — new packaging, new delivery mechanisms, new product forms — than formula innovations. Colgate Total was a formula innovation, yes, but its competitive advantage was as much about its regulatory positioning (FDA-approved therapeutic claims) as about its chemistry. Optic White's innovation was applying a professionally recommended whitening agent in a consumer toothpaste — a format transfer from the dental office to the bathroom.
Benefit: Format innovations often create larger addressable markets and deeper habit formation than formula innovations. They change behavior rather than merely improving outcomes.
Tradeoff: Format innovations are inherently more copiable than chemical patents. The collapsible tube was adopted by every competitor within years. Format advantages are first-mover advantages, not permanent moats.
Tactic for operators: When competing in a mature category, look for format innovations before formula innovations. Ask: is the product inconvenient, messy, intimidating, or difficult to integrate into daily routines? Solve the behavioral friction, and the market will follow.
Principle 4
Be there when the habit forms.
Colgate's international strategy can be summarized in a single sentence: enter emerging markets before the habit of daily toothbrushing is fully established, and become the brand that defines the category as it forms. In India, Latin America, and much of the developing world, Colgate did not displace an incumbent. It was the incumbent — the brand that arrived with modernization, that was present on the shelf when rural consumers first began purchasing commercially manufactured toothpaste.
The Bright Smiles, Bright Futures program is the operational expression of this principle: by providing oral health education and free product samples to hundreds of millions of children in developing markets, Colgate is simultaneously performing corporate social responsibility and executing what may be the most effective customer acquisition strategy in consumer goods history. A child who receives a free tube of Colgate at age six and is taught to brush her teeth with it may become a sixty-year customer.
Benefit: First-mover advantage in habit formation is extraordinarily durable. The brand that teaches you to brush becomes your default for life. Colgate's market share in many developing markets has been stable for decades.
Tradeoff: This strategy requires decades of upfront investment — distribution infrastructure, education programs, regulatory engagement — in markets that may not generate meaningful returns for years. It is fundamentally incompatible with short-term earnings optimization.
Tactic for operators: In any category where the user behavior is still forming, the race is not to build the best product but to be present at the moment of adoption. The first product a customer uses in a new behavior category has an outsized probability of becoming their permanent default.
Principle 5
Let the portfolio rhyme, not repeat.
The Hill's Pet Nutrition acquisition looked like a diversification. It was, in fact, a franchise extension — the application of Colgate's core competitive playbook (professional recommendation, science-based credibility, premium positioning) to a structurally similar but categorically distinct market. The key insight is that Colgate did not seek to replicate its oral care business in pet nutrition. It sought to replicate its competitive architecture — the structural relationships and trust mechanisms that generate durable market share.
A portfolio that rhymes is one where each business shares the same underlying competitive dynamics but operates in a different demand category. This is fundamentally different from the conglomerate model (unrelated diversification) and from the brand-extension model (putting the same brand name on different products). It is a playbook extension model: you take the operating system that works and install it on new hardware.
Benefit: Rhyming portfolios create diversification without diluting organizational capability. The same institutional skills — managing professional relationships, investing in clinical research, operating premium distribution channels — transfer across divisions.
Tradeoff: The temptation to extend the portfolio into categories that do not genuinely rhyme is ever-present. Not every professional-recommendation business has the same economics as oral care or pet nutrition. The company must be disciplined about where the playbook applies and where it does not.
Tactic for operators: Before diversifying, identify the structural mechanism that generates your competitive advantage. Then look for categories where that same mechanism operates but where no incumbent has fully exploited it. The goal is not to sell new products but to deploy old advantages in new territories.
Principle 6
Restructure continuously, not episodically.
Colgate-Palmolive's financial history is punctuated by restructuring charges — factory consolidations, workforce reductions, supply chain optimizations — that recur with metronomic regularity. To the untrained eye, this looks like a company perpetually in crisis. In reality, it is the opposite: a company that treats operational efficiency as a continuous process rather than a periodic event.
The distinction matters. Companies that restructure episodically — waiting until margins compress or competitive pressure forces action — tend to make dramatic, disruptive changes that create organizational trauma. Companies that restructure continuously make smaller, incremental adjustments that compound over time without destabilizing the business. The latter approach is harder to execute because it requires constant management attention and a willingness to take restructuring charges even in good years. But the cumulative effect on margins is substantial.
Benefit: Continuous restructuring creates a steady margin expansion trajectory that compounds over decades. Each basis point of gross margin improvement, applied to a $20 billion revenue base, generates meaningful incremental earnings.
Tradeoff: Perpetual restructuring can become a substitute for genuine strategic reinvention. Cutting costs is not the same as creating new value. There is a limit to how much margin you can extract from a mature business before you begin cannibalizing investment in growth.
Tactic for operators: Build restructuring into your annual operating rhythm, not your crisis-response playbook. Treat cost optimization as a permanent capability, not a project. The companies that compound margins most effectively are the ones that never stop looking for the next fifteen basis points.
Principle 7
Trade growth rate for growth permanence.
Colgate-Palmolive will never be a high-growth company. Its organic revenue growth rate typically ranges from low to mid-single digits. By the standards of the technology industry — or even of faster-growing consumer categories like energy drinks or athleisure — this is glacial. But the growth, such as it is, has been nearly uninterrupted for decades. The company has increased its dividend for over sixty consecutive years, a streak that places it among the elite "Dividend Aristocrats" of the S&P 500.
The tradeoff between growth rate and growth permanence is one that most business commentary ignores. A company growing at 4% per year for fifty years generates more cumulative value than a company growing at 25% per year for ten years and then stalling. Colgate-Palmolive has internalized this arithmetic at every level of its organization: its capital allocation, its geographic expansion, its product innovation, and its approach to competition all prioritize durability over speed.
Benefit: Permanent low growth compounds into extraordinary long-term value. Colgate's stock price trajectory — boring on any one-year chart, remarkable on a thirty-year chart — is the proof.
Tradeoff: The market periodically punishes companies that cannot deliver exciting growth narratives. Colgate trades at multiples that reflect its permanence but also cap its upside. The company will never be a ten-bagger for a growth investor.
Tactic for operators: Decide early whether you are building for velocity or for permanence. Both are valid. But the skills, capital structures, and organizational cultures that optimize for each are fundamentally incompatible. Trying to be both at once is the surest path to being neither.
Principle 8
Make the brand a generic noun.
In parts of India, Latin America, and sub-Saharan Africa, the word "Colgate" means "toothpaste." This is the ultimate expression of brand dominance — the point at which a brand transcends its corporate identity and becomes embedded in language itself. Xerox achieved this with photocopying. Band-Aid achieved it with adhesive bandages. Colgate achieved it with toothpaste, and it achieved it at global scale.
This level of brand genericization is not an accident. It is the product of decades of investment in distribution, advertising, professional endorsement, and community engagement — all converging to make Colgate the default mental model for an entire product category. Once achieved, it creates a form of competitive advantage that is nearly impossible to dislodge, because it operates at the level of cognition rather than preference. The consumer does not choose Colgate over alternatives. The consumer thinks Colgate when they think toothpaste.
Benefit: Generic-noun status creates the most durable form of brand moat in consumer goods. It short-circuits the purchase decision entirely, eliminating the need for active consideration and comparison.
Tradeoff: Generic-noun status carries a legal risk — trademark dilution — and a strategic risk: if the brand becomes too synonymous with the basic product, it can be difficult to premiumize. Consumers who think of Colgate as "just toothpaste" may not be willing to pay a premium for Colgate Optic White.
Tactic for operators: Ubiquity and premium positioning exist in tension. If your brand becomes generic, you must create sub-brands (as Colgate has with Total, Optic White, and others) to capture premium segments without diluting the mass-market franchise.
Principle 9
Premiumize from a position of mass dominance.
Colgate's premiumization strategy — expanding into whitening, sensitivity, therapeutic, and natural segments through sub-brands — is only possible because of its mass-market base. A company that starts premium and tries to go mass faces a different set of challenges than a company that starts mass and tries to go premium. Colgate's advantage is that its mass-market penetration gives it the shelf space, distribution relationships, retailer leverage, and brand recognition to launch premium sub-brands with immediate scale.
Optic White, launched in 2011, is the clearest example. The sub-brand targeted the high-margin whitening segment with a formula containing a professionally recommended whitening agent — a premium positioning backed by clinical credibility. It could not have succeeded as a standalone brand because it would have lacked the distribution infrastructure, retail relationships, and consumer trust that the Colgate parent brand provided.
Benefit: Premiumizing from a mass base is one of the few reliable strategies for driving margin expansion in low-growth categories. The existing infrastructure subsidizes the new product launch.
Tradeoff: Premium sub-brands can cannibalize the mass-market parent. Every consumer who trades up to Optic White is a consumer who is no longer buying standard Colgate. Managing the internal cannibalization requires careful price architecture.
Tactic for operators: If you dominate the mass tier, the path to margin expansion runs through premiumization — but only if the premium product offers a genuinely differentiated benefit. Slapping a higher price on the same product destroys trust. Offering a clinically validated superior benefit justifies the premium.
Principle 10
Survive the century. Then survive the next one.
Two hundred and nineteen years of continuous operation is not a strategy. It is the result of strategy — of a series of decisions, across generations of management, that prioritized institutional survival over short-term maximization. William Colgate's decision to make essential hygiene products. The second generation's decision to pivot into toothpaste. The merger with Palmolive. The international expansion. The Hill's acquisition. The continuous restructuring. The premiumization. Each decision was, in its moment, a bet on the future. In aggregate, they constitute the most remarkable track record of corporate endurance in American consumer goods.
The lesson is not that survival is guaranteed — it is not — but that survival is a skill, and it can be cultivated. Companies that survive centuries do so not because they are lucky but because they have built institutional mechanisms for adaptation: diversified revenue, conservative capital structures, deep management benches, and a cultural willingness to cannibalize today's business to secure tomorrow's.
Benefit: Institutional longevity is the ultimate competitive advantage. The longer you survive, the deeper your relationships, the stronger your brand, and the wider your distribution — all of which make it easier to survive even longer. Longevity compounds.
Tradeoff: The organizational cultures that optimize for survival can also optimize for risk aversion. A company that has lasted 219 years may be temperamentally incapable of making the bold, disruptive bets that a younger competitor would attempt without hesitation.
Tactic for operators: Build for permanence from day one. This does not mean being cautious — it means being structurally resilient. Diversify revenue streams. Maintain conservative leverage. Invest in management development. And attach your business to behaviors that will outlast you.
Conclusion
The Compounding of the Mundane
The Colgate playbook is, at its core, a theory of time. Not the Silicon Valley version of time — move fast, break things, disrupt before you're disrupted — but a different, older, slower theory: that the most durable competitive advantages are not the ones that generate the most excitement but the ones that compound the most quietly. Trust compounds. Habit compounds.
Distribution compounds. Professional endorsement compounds. The relationship between a dentist and a toothpaste brand compounds. The familiarity of a red tube on a bathroom shelf compounds.
Every principle in this playbook is, in some sense, a variation on that single theme: find a permanent behavior, earn the trust of the gatekeepers, be present when the habit forms, and then do not stop. Do not chase growth for its own sake. Do not diversify beyond the reach of your core competence. Do not mistake activity for progress. Just keep compounding.
Two hundred and nineteen years. The candle maker's shop on Dutch Street is long gone. The tube endures.
Part IIIBusiness Breakdown
The Business at a Glance
Current Vital Signs
Colgate-Palmolive FY2024
~$20BNet sales
~60%Gross margin (estimated)
~$62BMarket capitalization
~34,000Employees worldwide
200+Countries and territories
~40%Global toothpaste market share
~31%Global manual toothbrush market share
60+Consecutive years of dividend increases
Colgate-Palmolive is one of the largest and most geographically diversified consumer staples companies in the world. The company's revenue base spans every inhabited continent, with the majority of sales generated outside North America — a geographic mix that distinguishes it from many American-headquartered peers. The company operates through two primary segments: Oral, Personal and Home Care (which includes the Colgate, Palmolive, Irish Spring, Softsoap,
Speed Stick, Fabuloso, and Tom's of Maine brands, among others) and Hill's Pet Nutrition (which sells Science Diet and Prescription Diet through veterinary clinics and specialty pet retailers).
The company's scale is deceptive. Because its products are low-priced, high-frequency consumer staples, Colgate-Palmolive does not generate the headline revenue figures of a Procter & Gamble or a Nestlé. But its global penetration — the Colgate brand is found in more homes than any other single brand on earth — represents a distribution asset of extraordinary value. The company's market capitalization of approximately $62 billion reflects the market's assessment of the durability, if not the growth rate, of that franchise.
How Colgate-Palmolive Makes Money
Colgate-Palmolive generates revenue through the manufacture and sale of consumer products across four broad categories, plus a premium pet nutrition business that operates with a distinct economic model.
How Colgate-Palmolive's revenue breaks down by category
| Category | Key Brands | Approximate % of Revenue | Growth Profile |
|---|
| Oral Care | Colgate, Tom's of Maine, elmex | ~47% | Stable, premiumizing |
| Personal Care | Palmolive, Irish Spring, Softsoap, Speed Stick | ~15% | Mature |
| Home Care | Palmolive, Ajax, Fabuloso | ~15% | Mature |
Oral Care is the engine. Toothpaste and toothbrushes together constitute the single largest revenue stream and the foundation of the company's global brand franchise. The economics are favorable: toothpaste has high gross margins (raw materials are inexpensive relative to selling price), high repurchase frequency (consumers buy a new tube every one to three months), and minimal fashion risk. Growth comes from volume (population growth, emerging market penetration) and mix (premiumization toward whitening, sensitivity, and therapeutic sub-segments).
Hill's Pet Nutrition is the margin accelerator. Sold through veterinary clinics and specialty retailers at premium price points, Hill's operates with a fundamentally different distribution model than the company's mass-market consumer products. The professional recommendation channel (veterinarians) creates pricing power that mass-market oral care does not enjoy. Hill's has been Colgate-Palmolive's fastest-growing division for several years, benefiting from secular trends in pet humanization and the willingness of pet owners to spend on premium nutrition products.
Personal Care and Home Care are the cash generators — mature categories with stable revenues, limited growth, and the kind of predictable cash flows that fund dividends and share repurchases.
The company's pricing strategy across all segments is a blend of geographic price differentiation (lower prices in emerging markets, higher in developed markets), SKU-level tiering (mass products at accessible price points, premium sub-brands at higher margins), and periodic pricing actions to offset raw material cost inflation.
Competitive Position and Moat
Colgate-Palmolive competes in categories dominated by a small number of global players. The competitive landscape differs by segment:
Key competitors by segment with approximate scale
| Segment | Key Competitor | Competitor Scale | Colgate's Relative Position |
|---|
| Oral Care (Global) | Procter & Gamble (Crest, Oral-B) | ~$80B total P&G revenue | Colgate leads globally |
| Oral Care (U.S.) | P&G (Crest) | Crest ~30% U.S. share | Competitive duopoly |
| Home Care | Henkel, SC Johnson, P&G, Church & Dwight | Varies by market |
Moat sources:
-
Brand genericization. In large parts of the developing world, Colgate
is toothpaste. This cognitive lock-in is the deepest form of brand moat in consumer goods and is essentially unreplicable by competitors.
-
Professional recommendation infrastructure. Decades of investment in dental professional relationships — clinical trials, ADA endorsements, professional education, community outreach — create a trust-based moat that compounds over time. Hill's enjoys the same moat through veterinary relationships.
-
Distribution ubiquity. Colgate-Palmolive operates in more than 200 countries and territories. Its distribution infrastructure in emerging markets — where logistics are complex and shelf space is scarce — represents decades of accumulated investment that new entrants cannot replicate quickly.
-
Habit stickiness. Toothpaste purchasing is deeply habitual. Consumers exhibit extremely low switching rates in oral care, particularly outside the U.S. The cost of switching (negligible in dollar terms) is high in behavioral terms because the purchase is made reflexively, not deliberatively.
-
Regulatory credibility. Colgate Total's FDA approval as a therapeutic product and the ADA endorsement history create regulatory barriers that competitors must independently clear.
Where the moat is thin: In the U.S. market, Colgate faces intense competition from P&G's Crest/Oral-B franchise, particularly in electric toothbrushes, where P&G's Oral-B leads. Direct-to-consumer oral care brands (Harry's, quip, Bite) have chipped away at the margins of the traditional distribution model. The natural/organic toothpaste segment — where brands like Tom's of Maine (owned by Colgate since 2006), Hello, and Dr. Bronner's compete — is fragmented and commoditizing. Colgate's dominance is most secure in the developing world; in the U.S. and Europe, it must fight for every point of share.
The Flywheel
Colgate-Palmolive's competitive flywheel operates across a multi-decade time horizon, which is what makes it both powerful and easy to miss:
How trust, habit, and distribution compound into permanent market share
Step 1Clinical investment → Colgate invests in R&D and clinical trials, generating scientific evidence for product efficacy.
Step 2Professional endorsement → Dental professionals (or veterinarians, for Hill's) recommend Colgate products based on clinical evidence.
Step 3Consumer trust formation → Patients/pet owners adopt Colgate/Hill's based on professional recommendation, forming habits.
Step 4Distribution dominance → High market share gives Colgate leverage with retailers for shelf space, pricing, and promotional placement.
Step 5Scale economics → Distribution scale funds further R&D, advertising, and professional outreach, which feeds back to Step 1.
Step 6Community education → Programs like Bright Smiles, Bright Futures teach oral hygiene to children in developing markets, seeding the next generation of consumers and restarting the cycle.
Each link in this chain reinforces the others. Clinical investment earns professional endorsement, which builds consumer trust, which drives market share, which funds more clinical investment. The flywheel is slow — it takes years or decades to turn — but once spinning, it generates compounding returns that accelerate over time. Critically, the flywheel's most powerful link (community education in developing markets) operates on a generational time horizon: a child taught to brush with Colgate at age six may become a sixty-year customer. No quarterly earnings report captures this dynamic. It is invisible to short-term investors and invaluable to long-term ones.
Growth Drivers and Strategic Outlook
Colgate-Palmolive's growth outlook is shaped by five specific vectors:
1. Emerging market oral care penetration. Billions of people in Asia, Africa, and Latin America are still transitioning from non-commercial or irregular oral hygiene practices to daily toothbrushing with commercially manufactured products. Colgate's existing distribution infrastructure and brand recognition in these markets position it to capture a disproportionate share of this structural growth. The TAM is essentially the global population multiplied by the frequency of toothpaste purchase — an addressable market that grows with population, urbanization, and income.
2. Premiumization of oral care. The shift from mass-market toothpaste to premium sub-segments (whitening, sensitivity, natural/organic, therapeutic) is the primary lever for margin expansion in developed markets. Colgate's Optic White, Colgate Total, and elmex brands target higher price points. Each percentage point of mix shift toward premium products adds directly to gross margin.
3. Hill's Pet Nutrition growth. The secular trend of pet humanization — owners spending more on premium food, veterinary care, and pet wellness — is a multi-decade tailwind. Hill's prescription and science-based positioning aligns with this trend. Pet food is also recession-resistant: pet owners downgrade their own consumption before they downgrade their pets'.
4. E-commerce and direct-to-consumer expansion. While Colgate-Palmolive's distribution has historically been brick-and-mortar-centric, the company is investing in digital marketing, e-commerce partnerships, and direct-to-consumer capabilities. The shift to online purchase creates both opportunity (access to consumer data, margin improvement from reduced trade spend) and risk (loss of shelf-space advantage, price transparency).
5. Adjacencies in personal health. Colgate-Palmolive has quietly expanded its definition of oral care to include broader oral health — the intersection of dental hygiene with systemic health (oral-systemic health connections). This positioning could open adjacent categories (prescription oral care, diagnostic products, telehealth partnerships) over the medium term, though these remain speculative.
Key Risks and Debates
1. P&G's Oral-B electric toothbrush offensive. The global toothbrush market is bifurcating: manual toothbrushes (where Colgate leads with ~31% share) are a mature, low-growth category, while electric toothbrushes (where P&G's Oral-B is the dominant global brand) are the growth segment. Every manual toothbrush user who upgrades to an electric brush is a potential share loss for Colgate. The company's electric toothbrush portfolio is underdeveloped relative to P&G's — a strategic gap that could erode its overall oral care market position over the next decade.
2. Currency headwinds from emerging market exposure. Colgate-Palmolive's heavy revenue weighting toward emerging markets exposes it to structural currency translation risk. When the U.S. dollar strengthens against Latin American, Asian, and African currencies — as it has repeatedly over the past decade — reported revenue and earnings are mechanically depressed, even if underlying local-currency performance is strong. This is not a business risk (the underlying demand is real) but a financial reporting headwind that can depress the stock.
3. Raw material and packaging cost inflation. Toothpaste and soap manufacturing depend on commodity inputs (oils, fats, packaging materials, fluoride compounds) whose prices are volatile. The company's pricing power — its ability to pass through cost increases to consumers — is strong but not unlimited, particularly in emerging markets where consumer price sensitivity is high.
4. Private-label and DTC disruption in developed markets. Retailer private-label toothpaste brands have steadily gained share in developed markets, particularly in Europe. DTC oral care brands (quip, Bite, hismile) are attracting younger consumers through social media marketing and subscription models. While these threats are incremental — no single DTC brand has taken meaningful share from Colgate at global scale — the cumulative erosion is real and accelerating.
5. Regulatory and ESG scrutiny. Colgate's global operations expose it to a complex web of environmental, health, and safety regulations. The reformulation of Colgate Total (which replaced triclosan with stannous fluoride after concerns about triclosan's safety profile) illustrates the risk that key product ingredients can become regulatory liabilities. The company's sustainability commitments (recyclable packaging, carbon footprint reduction) create both opportunity and execution risk.
Why Colgate-Palmolive Matters
Colgate-Palmolive is not a company that will dominate the business press. It will not be the subject of breathless profiles about visionary founders or exponential growth curves. It will not be the stock that makes anyone rich overnight. But it is, for operators and investors alike, one of the most instructive businesses in the world — a 219-year case study in how competitive advantage compounds when you attach it to the right behaviors, build the right institutional relationships, and exercise the patience to let time do its work.
The principles embedded in Colgate's operating history — own the professional recommendation loop, be present when habits form, restructure continuously, premiumize from a mass base, trade growth rate for growth permanence — are applicable far beyond consumer staples. They describe, in distilled form, the mechanics of any business that aspires to outlast its current management, its current product cycle, and its current competitive environment.
What Colgate teaches, above all, is that the most powerful competitive advantages are often the most boring — the ones that accumulate so slowly they are invisible on any single earnings call, but which, over decades, create franchises that are essentially permanent. In a world obsessed with disruption, the red tube on the bathroom shelf is a quiet argument for the opposite: that some things endure not because they are innovative but because they are necessary, and because someone, two centuries ago, had the good sense to make them well.
